APA (7th ed.) Citation

Liu, B., Liu, Z., Chen, S., Ki, M., Erickson, C., Reis-Filho, J. S., . . . Chandarlapaty, S. (2021). Mutant SF3B1 promotes AKT- and NF-κB–driven mammary tumorigenesis. The Journal of clinical investigation, 131(1), . https://doi.org/10.1172/JCI138315

Chicago Style (17th ed.) Citation

Liu, Bo, et al. "Mutant SF3B1 Promotes AKT- and NF-κB–driven Mammary Tumorigenesis." The Journal of Clinical Investigation 131, no. 1 (2021). https://doi.org/10.1172/JCI138315.

MLA (9th ed.) Citation

Liu, Bo, et al. "Mutant SF3B1 Promotes AKT- and NF-κB–driven Mammary Tumorigenesis." The Journal of Clinical Investigation, vol. 131, no. 1, 2021, https://doi.org/10.1172/JCI138315.